The Effect of Intracavernosal Avanafil, a Newer Phosphodiesterase-5 Inhibitor, on Neonatal Type 2 Diabetic Rats With Erectile Dysfunction

Yilmaz, Didem; Bayatli, Nur; Un, Ozge; Kadowitz, Philip; Sikka, Suresh; GÜR, SERAP

doi:10.1016/j.urology.2013.10.021

The Effect of Intracavernosal Avanafil, a Newer Phosphodiesterase-5 Inhibitor, on Neonatal Type 2 Diabetic Rats With Erectile Dysfunction

Atıf İçin Kopyala

Yilmaz D., Bayatli N., Un O., Kadowitz P. J., Sikka S. C., GÜR S.

UROLOGY, cilt.83, sa.2, 2014 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 83 Sayı: 2
Basım Tarihi: 2014
Doi Numarası: 10.1016/j.urology.2013.10.021
Dergi Adı: UROLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Ankara Üniversitesi Adresli: Evet

Özet

OBJECTIVE To determine the effect of avanafil, a novel phosphodiesterase-5 inhibitor, on the treatment of erectile dysfunction associated with type 2 diabetes mellitus (T2DM).